Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    19683731 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Safety and Efficacy Study of Transdermal Oxybutynin to Treat Overactive Bladder With a Neurological Condition
Condition: Detrusor Hyperreflexia
Intervention: Drug: Oxybutynin
2 Recruiting Safety and Efficacy Evaluation of Oxybutynin Topical Gel In Children With Neurogenic Bladder
Conditions: Overactive Detrusor;   Neurogenic Bladder
Intervention: Drug: Oxybutynin

Indicates status has not been verified in more than two years